Zylö Therapeutics

Zylö Therapeutics

Zylö Therapeutics has an innovative sustained-release drug-delivery system
Greenville United States (HQ)

Zylö Therapeutics Company information

Edit
Date
Ownership
Firm valuation
€15—22m (Dealroom.co estimates Sep 2019.)
  • Edit
DateInvestorsAmountRound
$4mSERIES A
Total FundingFunding not available

Recent News about Zylö Therapeutics

Edit
LocationEdit
United States, Greenville
Are you an employee or an investor of this company?
Add your profile